Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis

The use of immunobiological agents for the treatment of autoimmune diseases is increasing in medical practice. Anti-TNF therapies have been increasingly used in refractory autoimmune diseases, especially rheumatoid arthritis, with promising results. However, the use of such therapies has been associ...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Dias, Olívia Meira, Pereira, Daniel Antunes Silva, Baldi, Bruno Guedes, Costa, André Nathan, Athanazio, Rodrigo Abensur, Kairalla, Ronaldo Adib, Carvalho, Carlos Roberto Ribeiro
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Sociedade Brasileira de Pneumologia e Tisiologia 2014
Θέματα:
Case Report
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075924/
https://ncbi.nlm.nih.gov/pubmed/24626274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1806-37132014000100012
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια